The DNAJC1 Knockout A-549 Polyclonal Cells are a heterogeneous A-549 human lung adenocarcinoma cell population created by CRISPR/Cas9-mediated disruption of DNAJC1. This polyclonal knockout model offers a genetically diverse background suitable for studying loss-of-function effects while minimizing clonal bias. The cells provide a robust system for examining DNAJC1-dependent processes in a cancer-relevant epithelial context.
A-549 cells were established from a 58-year-old Caucasian male with lung carcinoma and serve as a principal model of non-small cell lung cancer (NSCLC). These adherent epithelial cells express wild-type p53 and are commonly employed in drug response and oncogenic signaling studies. Their NSCLC origin makes them an appropriate host for investigating the role of ER proteostasis in tumor biology and therapeutic resistance.
DNAJC1 encodes an ER-resident J-domain co-chaperone that activates Hsp70 chaperones, notably HSPA5/BiP, by stimulating ATP hydrolysis. This activity is essential for co- and post-translational protein import via the SEC61 complex, nascent chain folding, and ER-associated degradation (ERAD). DNAJC1 transcription is induced by ATF6, XBP1, and ATF4 under ER stress, integrating it into the unfolded protein response (UPR) network. It interacts directly with HSPA5, SEC61 components, and ERAD machinery, and functions alongside UPR sensors ERN1/IRE1?? and EIF2AK3/PERK. Knockout of DNAJC1 disrupts HSPA5-mediated folding capacity, leading to accumulation of misfolded clients and chronic UPR activation, which can modulate apoptosis and autophagy pathways in cancer cells.
In the A-549 NSCLC context, DNAJC1 knockout perturbs ER proteostasis, offering a powerful model to investigate UPR-driven adaptation in lung cancer. Cancer cells often exploit chaperone networks to handle oncogenic and therapeutic stress; loss of DNAJC1 may unmask vulnerabilities to ER stressor agents. The polyclonal population captures diverse genetic responses, providing a faithful representation of tumor heterogeneity. This system enables dissection of DNAJC1-HSPA5 interactions in drug sensitivity and identification of synthetic-lethal targets in UPR signaling.
These cells support a range of functional studies, including western blotting for UPR markers such as HSPA5, phospho-EIF2S1, and spliced XBP1, along with RT-qPCR analysis of XBP1 mRNA processing. ER stress reporter assays and tunicamycin/thapsigargin viability screens can quantify chemosensitivity shifts. Co-immunoprecipitation with HSPA5 and immunofluorescence for ER morphology enable biochemical and structural studies. Flow cytometry for apoptosis aids in defining DNAJC1??s role in cell death regulation. Contact Ascent Research for technical guidance.
